Composition:

Each Gantolief tablet contains 50 mg itopride hydrochloride.

Therapeutic Indications:

Treatment of gastrointestinal symptoms caused by gastric dysmotility and delayed gastric emptying, such as sensation of bloating, early satiety, postprandial fullness, upper abdominal pain or discomfort, anorexia, heartburn, nausea and vomiting, functional (non-ulcer) dyspepsia or chronic gastritis.

Approved by Egyptian Drug Authority: HF0294OA4548/102025 . Invalidation date: 20/10/2026

Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at www.edaegypt.gov.eg”